Novel human coronavirus infection: Difference between revisions
Line 44: | Line 44: | ||
==Case Studies== | ==Case Studies== | ||
[[Novel human coronavirus infection case study one|Case #1]] | [[Novel human coronavirus infection case study one|Case #1]] | ||
==Related Chapters== | |||
* [[SARS]] | |||
* [[Coronavirus]] | |||
==External Links== | ==External Links== |
Revision as of 20:15, 1 January 2013
Coronavirus | ||||||||
---|---|---|---|---|---|---|---|---|
Virus classification | ||||||||
|
Novel Human Coronavirus Infection Microchapters |
Differentiating Novel Human Coronavirus Infection from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Novel human coronavirus infection On the Web |
American Roentgen Ray Society Images of Novel human coronavirus infection |
Directions to Hospitals Treating Novel human coronavirus infection |
Risk calculators and risk factors for Novel human coronavirus infection |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]
Synonyms and keywords: Human betacoronavirus 2c EMC/2012; novel coronavirus
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Case Definitions | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies